Arecor

CAMBRIDGE, England, November 10, 2011 - Arecor, the leading company in advancing aqueous formulation solutions for proteins, peptides and vaccines, is pleased to announce the appointment of Dr Sarah Howell as Chief Operating Officer.Dr Howell will be responsible for the operations of Arecor, with a focus on developing and maintaining Arecor's upward growth curve ensuring the company continues to deliver exceptional formulation solutions and performance to the highest standards across the industry.

CAMBRIDGE, England, June 14, 2011 - Arecor and GSK have entered into a license agreement to develop advanced formulations of vaccines combining Arecor's unique formulation technologies with GSK's proprietary vaccines.

CAMBRIDGE, England, April 13, 2010 - Genzyme Corporation and Arecor Limited today signed an agreement providing for extensive collaboration on developing advanced formulations for protein therapeutics.